Press Release | February 4, 2024
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
Read More
Press Release | December 14, 2023
First In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna Collaboration
Read More
Press Release | December 7, 2023
Vittoria Biotherapeutics Announces FDA Clearance of IND Application for VIPER-101 to Treat T-Cell Lymphoma
Read More
Press Release | December 5, 2023
Dragonfly Therapeutics Initiates Phase 1/1b Study of its IL-2 Immunotherapy in Patients with Advanced Solid Tumors
Read More
